Absci in GenAI Drug Discovery Collaboration with Oracle and AMD

AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 - Absci, a clinical-stage biotech company advancing therapeutics with generative AI, today announced a collaboration with Oracle Cloud Infrastructure (OCI)andAMD to accelerate drug discovery. Absci's generative AI Drug Creation Platform leverages OCI's AI infrastructure and AMD's hardware, consolidating its infrastructure with the goal of accelerating its biologics [...]
The post Absci in GenAI Drug Discovery Collaboration with Oracle and AMD appeared first on Inside HPC & AI News | High-Performance Computing & Artificial Intelligence.